Repetto F - Search Results

1

Guselkumab in the treatment of severe hidradenitis suppurativa, a promising role?

Burzi L, Repetto F, Ramondetta A, Rozzo G, Licciardello M, Ribero S, Quaglino P, Dapavo P. Burzi L, et al. Among authors: repetto f. Dermatol Ther. 2021 May;34(3):e14930. doi: 10.1111/dth.14930. Epub 2021 Mar 14. Dermatol Ther. 2021. PMID: 33665949 No abstract available.

2

Cupping in Herpes zoster infection.

Burzi L, Repetto F, Zenone M, Siliquini N, Panzone M, Ribero S. Burzi L, et al. Among authors: repetto f. Ital J Dermatol Venerol. 2022 Apr;157(2):206-207. doi: 10.23736/S2784-8671.21.07008-0. Epub 2021 May 28. Ital J Dermatol Venerol. 2022. PMID: 34044511 No abstract available.

3

Certolizumab pegol and its role in pregnancy-age hidradenitis suppurativa.

Repetto F, Burzi L, Ramondetta A, Rozzo G, Licciardello M, Ribero S, Quaglino P, Dapavo P. Repetto F, et al. Int J Dermatol. 2022 May;61(5):e182-e184. doi: 10.1111/ijd.15742. Epub 2021 Jul 16. Int J Dermatol. 2022. PMID: 34270087 No abstract available.

4

Persistent eruptive lentiginosis in a psoriatic patient after 4-year effective treatment with ustekinumab.

Parietti M, Burzi L, Ribero S, Gallo G, Repetto F, Dapavo P. Parietti M, et al. Among authors: repetto f. Dermatol Ther. 2022 Jun;35(6):e15468. doi: 10.1111/dth.15468. Epub 2022 Mar 28. Dermatol Ther. 2022. PMID: 35315185 No abstract available.

5

Efficacy and Safety of Risankizumab in Hidradenitis Suppurativa: A Case Series.

Repetto F, Burzi L, Ribero S, Quaglino P, Dapavo P. Repetto F, et al. Acta Derm Venereol. 2022 Sep 28;102:adv00780. doi: 10.2340/actadv.v102.2926. Acta Derm Venereol. 2022. PMID: 35971829 Free PMC article. No abstract available.

6

Switching from adalimumab originator to biosimilars in hidradenitis suppurativa: What's beyond cost-effectiveness?

Roccuzzo G, Rozzo G, Burzi L, Repetto F, Dapavo P, Ribero S, Quaglino P. Roccuzzo G, et al. Among authors: repetto f. Dermatol Ther. 2022 Nov;35(11):e15803. doi: 10.1111/dth.15803. Epub 2022 Sep 14. Dermatol Ther. 2022. PMID: 36062429 Free PMC article.

7

Paradoxical psoriasiform reactions during treatment with adalimumab for hidradenitis suppurativa: Real-life experience and therapeutic response to other biological drugs.

Burzi L, Repetto F, Ribero S, Mastorino L, Quaglino P, Dapavo P. Burzi L, et al. Among authors: repetto f. Dermatol Ther. 2022 Dec;35(12):e15866. doi: 10.1111/dth.15866. Epub 2022 Oct 13. Dermatol Ther. 2022. PMID: 36175129 Free PMC article.

8

Drug Survival of Anti Interleukin-17 and Interleukin -23 Agents after Adalimumab Failure in Hidradenitis Suppurativa: A Pilot Study.

Repetto F, Roccuzzo G, Burzi L, Mastorino L, Dapavo P, Quaglino P, Ribero S. Repetto F, et al. Acta Derm Venereol. 2023 Apr 19;103:adv5278. doi: 10.2340/actadv.v103.5278. Acta Derm Venereol. 2023. PMID: 37073963 Free PMC article. No abstract available.

9

Anti-IL17 Secukinumab in hidradenitis suppurativa: A long-term drug survival analysis.

Roccuzzo G, Repetto F, Giordano S, Sarda C, Comes A, Dapavo P, Quaglino P, Ribero S. Roccuzzo G, et al. Among authors: repetto f. Exp Dermatol. 2024 Jul;33(7):e15140. doi: 10.1111/exd.15140. Exp Dermatol. 2024. PMID: 39032087

10

Pyoderma gangrenosum during infliximab in severe hidradenitis suppurativa: A paradoxical event.

Giordano S, Repetto F, Boskovic S, Roccuzzo G, Ortoncelli M, Dapavo P, Ribero S, Quaglino P. Giordano S, et al. Among authors: repetto f. Australas J Dermatol. 2024 Oct 3. doi: 10.1111/ajd.14367. Online ahead of print. Australas J Dermatol. 2024. PMID: 39361521 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

48 results

Search Page

Filters